within Pharmacolibrary.Drugs.ATC.J;

model J01EC20
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.9,
    Cl             = 0.25,
    adminDuration  = 600,
    adminMass      = 0.96,
    adminCount     = 1,
    Vd             = 0.0012,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0033333333333333335,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>A combination antibacterial drug consisting of sulfamethoxazole, a sulfonamide, and trimethoprim, a dihydrofolate reductase inhibitor. This combination is used to treat urinary tract infections, respiratory tract infections and other bacterial infections, and is widely approved for clinical use.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult volunteers after a single oral dose of 800 mg sulfamethoxazole combined with 160 mg trimethoprim (co-trimoxazole).</p><h4>References</h4><ol><li><p>Petritz, OA, et al., &amp; Flammer, K (2023). Pharmacokinetics and Safety of Sulfamethoxazole-Trimethoprim After Oral Administration of Single and Multiple Doses to Rhode Island Red Chickens (. <i>Journal of avian medicine and surgery</i> 37(1) 1–12. DOI:<a href=&quot;https://doi.org/10.1647/22-00020&quot;>10.1647/22-00020</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/37358198/&quot;>https://pubmed.ncbi.nlm.nih.gov/37358198</a></p></li><li><p>Wu, YSS, et al., &amp; Gonzalez, D (2021). External Evaluation of Two Pediatric Population Pharmacokinetics Models of Oral Trimethoprim and Sulfamethoxazole. <i>Antimicrobial agents and chemotherapy</i> 65(7) e0214920–None. DOI:<a href=&quot;https://doi.org/10.1128/AAC.02149-20&quot;>10.1128/AAC.02149-20</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33903114/&quot;>https://pubmed.ncbi.nlm.nih.gov/33903114</a></p></li><li><p>Sullins, AK, &amp; Abdel-Rahman, SM (2013). Pharmacokinetics of antibacterial agents in the CSF of children and adolescents. <i>Paediatric drugs</i> 15(2) 93–117. DOI:<a href=&quot;https://doi.org/10.1007/s40272-013-0017-5&quot;>10.1007/s40272-013-0017-5</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/23529866/&quot;>https://pubmed.ncbi.nlm.nih.gov/23529866</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end J01EC20;
